The Biotech Growth Trust PLC (BIOG)

Category Sector Equity Biotechnology

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Sell

1,012.00p

Buy

1,038.00p

arrow-down-3.667p (-0.36%)

Discount/Premium

-6.08%

Estimated NAV

1,090.336p

Prices updated at 09 May 2024, 11:57 BST

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

FTSE All-Share

0.11%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

	1,024.00
Launch date	23 Jun 1997
	1,032.00p - 1,013.50p
	1,048.00p - 715.00p
	1,106.44 as of 07 May 2024
Ongoing charge audited (%)	1.1
	1.08
	0.93
	0.00
	66,629.82
	33.37m
	341.73m
	105.07
	None
	£396.46m
	£363.87m
	-7.54
	-7.46
	-6.17
Fund comparative index	NASDAQ Biotechnology TR GBP
	Daily
	0.07m
	0.59m
	GB0000385517

Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.